ProQR Therapeutics N.V. (PRQR)

NASDAQ: PRQR · IEX Real-Time Price · USD

1.35

+0.02 (1.50%)

Sep 29, 2023, 10:30 AM EDT - Market open

Balance Sheet (Annual)

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Cash & Equivalents	94.78	187.52	75.84	111.95	105.58	48.1	59.2	94.87	112.74	4.13
Cash & Cash Equivalents	94.78	187.52	75.84	111.95	105.58	48.1	59.2	94.87	112.74	4.13
Cash Growth	-49.46%	147.27%	-32.26%	6.03%	119.51%	-18.75%	-37.60%	-15.85%	2630.35%	-
Receivables	59.08	3.4	3.76	1.87	1.54	2.06	2.42	1.95	0.74	0.06
Other Current Assets	0.61	0.56	0.42	0.85	1.24	0.4	0.4	0.96	0.43	0.07
Total Current Assets	154.46	191.48	80.02	114.67	108.37	50.56	62.02	97.77	113.9	4.26
Property, Plant & Equipment	16.24	17.47	18.6	2.44	1.86	2.51	3.44	2.2	1.19	0.2
Long-Term Investments	0.62	0.63	0.11	0.43	0	0	0	0	0	0
Goodwill and Intangibles	0	0	0	0	0	0.04	0.09	0.14	0.16	0.04
Total Long-Term Assets	16.86	18.1	18.71	2.87	1.86	2.54	3.53	2.34	1.35	0.24
Total Assets	171.32	209.58	98.73	117.54	110.23	53.1	65.54	100.11	115.25	4.5
Accounts Payable	0.39	0.19	0.22	0.45	0.14	0.55	0.33	0.89	1.25	0.75
Deferred Revenue	71.21	19.8	0.7	0.71	0.55	0.35	0	0.14	0	0
Current Debt	3.89	6.31	2.4	0.85	0	1.96	0	0.02	0.03	2.55
Other Current Liabilities	-54.5	1.3	6.99	8.99	7.48	5.64	6.38	4.44	1.73	0.31
Total Current Liabilities	20.99	27.6	10.3	10.99	8.16	8.49	6.71	5.49	3.01	3.6
Long-Term Debt	18.08	54.07	31.88	12.71	9.39	5.28	5.7	4.82	2.83	0.99
Other Long-Term Liabilities	65.57	14.69	0	0	0	0	0	0	0	0
Total Long-Term Liabilities	83.65	68.75	31.88	12.71	9.39	5.28	5.7	4.82	2.83	0.99
Total Liabilities	104.64	96.35	42.18	23.7	17.55	13.78	12.41	10.31	5.84	4.59
Total Debt	21.97	60.37	34.28	13.56	9.39	7.24	5.7	4.84	2.86	3.54
Debt Growth	-63.61%	76.13%	152.78%	44.47%	29.57%	27.15%	17.73%	69.02%	-19.12%	-
Common Stock	447.74	431.6	314.84	306.08	248.36	158.73	128.87	126.43	125.2	3.58
Retained Earnings	-380.68	-317.77	-257.75	-211.75	-155.44	-119.37	-75.73	-36.63	-15.8	-3.67
Comprehensive Income	0	0	0	0	0	0	0	0	0	0
Shareholders' Equity	67.06	113.83	57.09	94.33	92.92	39.36	53.14	89.8	109.4	-0.09
Net Cash / Debt	72.8	127.15	41.56	98.39	96.19	40.86	53.5	90.03	109.87	0.59
Net Cash / Debt Growth	-42.74%	205.94%	-57.76%	2.28%	135.45%	-23.64%	-40.57%	-18.06%	18554.16%	-
Net Cash Per Share	1.02	1.98	0.83	2.40	2.82	1.61	2.29	3.86	9.91	0.11
Working Capital	133.47	163.89	69.72	103.67	100.21	42.07	55.31	92.28	110.88	0.66
Book Value Per Share	0.94	1.77	1.14	2.30	2.73	1.55	2.28	3.85	9.87	-0.02

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).